Introduction of a Specific Restricted Stock Compensation Plan
First written in FY2018. 6 of 12 entries say "Advanced", first in FY2019. Latest entry: 2026-07-24.
- FY2026AdvancedAnnual report
「For restricted stock compensation, 16,978 shares were granted in fiscal 2025 to 3 directors, excluding outside directors.」
For restricted stock compensation, the company updated the grant record from 3 directors and 6,920 shares in the previous fiscal year to 3 directors and 16,978 shares in fiscal 2025. - 2026-06-03RestatedGeneral Meetings of Shareholders
「The total amount of monetary compensation receivables to be paid to the eligible directors for the grant of restricted stock under this proposal will be no more than ¥120 million per year, an amount deemed reasonable in light of the purposes described above.」
The Company has reiterated the framework for restricted stock compensation, with annual monetary compensation of no more than ¥120 million and annual issuance or disposal of no more than 48,000 shares. - FY2025Updated the record of stock-based compensation grantsAnnual report
「For restricted stock compensation, 6,920 shares were granted in fiscal 2024 to 3 directors, excluding outside directors.」
The company has disclosed the grant of 6,920 shares to 3 directors as restricted stock compensation. The number of shares granted decreased from 14,450 in the previous fiscal year. - FY2024Updated the record of stock-based compensation grantsAnnual report
「For restricted stock compensation, 14,450 shares were granted in fiscal 2023 to 3 directors, excluding outside directors.」
The company has disclosed the grant of 14,450 shares to 3 directors as restricted stock compensation. - FY2023AdvancedAnnual report
「For restricted stock compensation, 16,327 shares were granted in fiscal 2022 to 3 directors, excluding outside directors, representing approximately 13% of compensation.」
For restricted stock compensation, the company updated the grant record and compensation mix from 4 directors, 9,244 shares and approximately 10% in the previous fiscal year to 3 directors, 16,327 shares and approximately 13%. - FY2022Updated the record of stock-based compensation grantsAnnual report
「For restricted stock compensation, 9,244 shares were granted in fiscal 2021 to 4 directors, excluding outside directors, representing approximately 10% of compensation.」
The company has disclosed the grant of 9,244 shares to 4 directors as restricted stock compensation and its approximately 10% share of total compensation. - FY2021AdvancedAnnual report
「For restricted stock compensation, 9,570 shares were granted in fiscal 2020 to 4 directors, excluding outside directors, representing approximately 8% of compensation.」
The company disclosed the record of restricted stock grants and their proportion of total compensation. It also specified the composition of compensation, with base compensation, performance-linked compensation and stock-based compensation accounting for approximately 30–70%, 20–40% and 5–20%, respectively. - FY2020AdvancedAnnual report
「In fiscal 2019, 11,500 shares were granted to 5 directors, with the transfer restrictions set to be lifted when they leave office.」
For restricted stock compensation, the grant record increased from 4 directors and 5,000 shares in the previous fiscal year to 5 directors and 11,500 shares in fiscal 2019. - FY2019AdvancedAnnual report
「In fiscal 2018, 5,000 shares were granted to 4 directors as restricted stock compensation. The restriction period is set at 30 years.」
Regarding the restricted stock compensation plan approved for introduction in the previous fiscal year, the company has disclosed the grant of 5,000 shares to 4 directors and a 30-year restriction period. - FY2018First statedAnnual report
「At the 98th Annual General Meeting of Shareholders held on 22 June 2018, approval was obtained to introduce a restricted stock compensation plan, and new stock-based compensation will be added for inside directors.」
The company has disclosed approval to introduce a restricted stock compensation plan for inside directors.